Skip to main content

Published locations for Ixekizumab Met Phase 3 Trial Endpoint in Juvenile PsA, Enthesitis-Related Arthritis

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. Ixekizumab Met Phase 3 Trial Endpoint in Juvenile PsA, Enthesitis-Related Arthritis

User login

  • Reset your password
  • /content/ixekizumab-met-phase-3-trial-endpoint-juvenile-psa-enthesitis-related-arthritis
  • /edermatologynews/article/269711/pediatrics/ixekizumab-met-phase-3-trial-endpoint-juvenile-psa
  • /pediatricnews/article/269711/pediatrics/ixekizumab-met-phase-3-trial-endpoint-juvenile-psa
  • /rheumatologynews/article/269711/pediatrics/ixekizumab-met-phase-3-trial-endpoint-juvenile-psa
  • /pediatrics/article/269711/pediatrics/ixekizumab-met-phase-3-trial-endpoint-juvenile-psa-enthesitis
  • /rheumatology/article/269711/pediatrics/ixekizumab-met-phase-3-trial-endpoint-juvenile-psa-enthesitis
  • /dermatology/article/269711/pediatrics/ixekizumab-met-phase-3-trial-endpoint-juvenile-psa-enthesitis